Grifols reported EUR119.6M in Ordinary Share Capital for its fiscal quarter ending in December of 2024.


Ordinary Share Capital Change Date
Alaunos Therapeutics USD 2K 0 Dec/2024
GlaxoSmithKline GBP 4.15B 2.8B Jun/2025
Grifols EUR 119.6M 0 Dec/2024
Life Technologies USD 92.87M 92.79M Jun/2025